about
Novel oral fast-disintegrating drug delivery devices with predefined inner structure fabricated by Three-Dimensional Printing.Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.Understanding pharmaceutical polymorphic transformations II: crystallization variables and influence on dosage forms.Resveratrol (3,5,4'-trihydroxystilbene) and its properties in oral diseases.Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration.Study of particle rearrangement, compression behavior and dissolution properties after melt dispersion of ibuprofen, Avicel and AerosilCo-precipitation with PVP and Agar to Improve Physicomechanical Properties of Ibuprofen.Use of first derivative of displacement vs. force profiles to determine deformation behavior of compressed powders.Co-precipitation with PVP and Agar to Improve Physicomechanical Properties of Ibuprofen.Influence of polymers/excipients on development of agglomerated crystals of secnidazole by crystallo-co-agglomeration technique to improve processability.How suitable is the measurement of take-off forces for detection of sticking during direct compression of various ibuprofen tablet formulations?Impact of micromeritic properties of an active pharmaceutical ingredient on its compaction behavior.Assessing compressibility and compactibility of powder formulations with Near-Infrared Spectroscopy.Ultrasound-assisted preparation of novel ibuprofen-loaded excipient with improved compression and dissolution properties.Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.Effect of milling on particle shape and surface energy heterogeneity of needle-shaped crystals.Decoupling the contribution of surface energy and surface area on the cohesion of pharmaceutical powders.Modification of the crystal habit of celecoxib for improved processability.Hopper Growth of Salt Crystals.Influence of binder type and process parameters on the compression properties and microbial survival in diclofenac tablet formulations
P2860
Q33410023-D6FA94AA-8568-45E2-B191-71661D8090A3Q38270691-51141C85-53D7-4D2D-9E75-FB3F6FE41D09Q38543393-60AFB4EC-0432-4A2A-AD53-9F82382B3C82Q38663394-B3C3C176-CBAC-4DBF-8DE4-BB858D6165B5Q39650017-2D3E6AFC-4838-497A-9F78-F8B415D8611EQ41256987-DE38093F-FCB6-467C-BB3B-D874FB4A11D1Q42274956-207C06EA-49EC-4F3E-A95A-E0E6FAB2A3D8Q43240337-C406535B-0AED-4321-B6BC-FCBE47A8F640Q43713802-EF1DB677-9080-4578-8C64-854621815DA8Q43745626-5453826E-B88E-4206-A064-4B48D4F64FFCQ44257555-A923EA7A-84AB-463D-9D23-40875CBB6E20Q45193384-65E36E08-613C-4388-B17D-6686C4151404Q46303020-8424BAB2-083A-4F0D-BDB7-54AB3DFDE0F1Q51531411-BC0D18C5-BBDA-4FAA-9338-7C31070CBD85Q51706707-F9B409E4-1C9B-400E-BEB8-39ACE7ED1544Q53152588-E74538D9-189C-41E9-B47F-9706F3FF0B34Q53498451-FEBE4C56-C9F4-4E32-870A-1C3AE1AA1FBEQ53736442-79A117B9-7952-4828-AEF7-291C249C4A55Q55006730-1CE3CFA1-6E40-4527-A689-0EBAFE019D62Q56034772-CBF75D8B-DB94-48BB-B97A-30124D865EC3
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Crystal habit and tableting behavior.
@en
Crystal habit and tableting behavior.
@nl
type
label
Crystal habit and tableting behavior.
@en
Crystal habit and tableting behavior.
@nl
prefLabel
Crystal habit and tableting behavior.
@en
Crystal habit and tableting behavior.
@nl
P1476
Crystal habit and tableting behavior.
@en
P2093
Bernd W Müller
Norbert Rasenack
P356
10.1016/S0378-5173(02)00296-X
P407
P577
2002-09-01T00:00:00Z